Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

317 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Defining a therapeutic dose of peripheral blood stem cells.
Bender JG, To LB, Williams S, Schwartzberg LS. Bender JG, et al. Among authors: schwartzberg ls. J Hematother. 1992 Winter;1(4):329-41. doi: 10.1089/scd.1.1992.1.329. J Hematother. 1992. PMID: 1285382 Review.
Collection of peripheral blood stem cells following administration of paclitaxel, cyclophosphamide, and filgrastim in patients with breast and ovarian cancer.
Weaver CH, Schwartzberg LS, Birch R, Greco FA, Hainsworth J, Drapkin R, Campos L, Grapski R, Schwerkoske J, Lautersztain J, Hazelton B, Schnell F, Babcock W, Buckner CD. Weaver CH, et al. Among authors: schwartzberg ls. Biol Blood Marrow Transplant. 1997 Jun;3(2):83-90. Biol Blood Marrow Transplant. 1997. PMID: 9267668 Clinical Trial.
Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte-colony-stimulating factor: an analysis of 497 patients.
Weaver CH, Schwartzberg LS, Birch R, Greco FA, Rhinehart S, Hainsworth J, Beeker T, Price H, Geier L, Foster J, West J, Hazelton B, Buckner CD. Weaver CH, et al. Among authors: schwartzberg ls. Transfusion. 1997 Sep;37(9):896-903. doi: 10.1046/j.1537-2995.1997.37997454014.x. Transfusion. 1997. PMID: 9308634 Clinical Trial.
A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapy.
Weaver CH, Zhen B, Schwartzberg L, Walker C, Upton S, Buckner CD. Weaver CH, et al. Among authors: schwartzberg l. Am J Clin Oncol. 1998 Aug;21(4):408-12. doi: 10.1097/00000421-199808000-00019. Am J Clin Oncol. 1998. PMID: 9708644 Clinical Trial.
Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content.
Weaver CH, Potz J, Redmond J, Tauer K, Schwartzberg LS, Kaywin P, Drapkin R, Grant B, Unger P, Allen C, Longin K, Zhen B, Hazelton B, Buckner CD. Weaver CH, et al. Among authors: schwartzberg ls. Bone Marrow Transplant. 1997 Jun;19(11):1103-10. doi: 10.1038/sj.bmt.1700808. Bone Marrow Transplant. 1997. PMID: 9193753
A randomized trial of two doses of cyclophosphamide with etoposide and G-CSF for mobilization of peripheral blood stem cells in 318 patients with stage II-III breast cancer.
Schwartzberg LS, Weaver CH, Birch R, Manner C, Tauer K, Beeker T, Morgan-Ihrig C, MacAneny B, Leff R, Smith R, Hainsworth J, Greco T, Schwerkoske J, Murphy MN, Buckner CD. Schwartzberg LS, et al. J Hematother. 1998 Apr;7(2):141-50. doi: 10.1089/scd.1.1998.7.141. J Hematother. 1998. PMID: 9597571 Clinical Trial.
317 results